U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Remifentanil Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 06/28/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA, LLC (Reverified 09/04/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 1 mg/1 mL (NDC 63323-723-03) Unavailable Backordered. Next release September 2024. Check wholesalers for inventory. Demand increase for the drug
Injection, 1 mg/1 mL (NDC 63323-724-05) Unavailable Backordered. Next release September 2024. Check wholesalers for inventory. Demand increase for the drug
Injection, 1 mg/1 mL (NDC 63323-725-10) Unavailable Backordered. Next release not available at this time; Check wholesalers for inventory. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Revised 09/16/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 1 mg per vial (NDC 0143-9391-10) Unavailable Additional lots will be available in the October 2024 timeframe. Product will be made available as it is released. Demand increase for the drug
Injection, 2 mg per vial (NDC 0143-9392-10) Unavailable Additional lots will be available in the January - February 2025 timeframe. Product will be made available as it is released. Demand increase for the drug
Injection, 5 mg per vial (NDC 0143-9393-10) Unavailable Additional lots will be available in the January - February 2025 timeframe. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional, a Viatris Company (Reverified 09/05/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ultiva, Injection, 2 mg (NDC 72078-035-02) Available
Ultiva, Injection, 5 mg (NDC 67457-198-10) Unavailable Next supply in Q4-2024. Demand increase for the drug
Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01) Available
Back to Top